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Abstract 83 
This study presents the development of a worldwide inter-laboratory testing scheme for the analysis 84 
of seven illicit drug residues in different matrices (standard solutions, tap- and wastewater). By 85 
repeating this exercise for six years with participation of 37 laboratories from 25 countries, the 86 
testing scheme was substantially improved based on experiences gained across the years (e.g. matrix 87 
type, sample conditions, spiking levels). From the exercises, (pre-)analytical issues (e.g. pH 88 
adjustment, filtration) were revealed for some analytes which resulted in formulation of best-89 
practice protocols, both for inter-laboratory setup and analytical procedures. The results illustrate 90 
the effectiveness of the inter-laboratory testing scheme in assessing laboratory performance in the 91 
framework of illicit drug analysis in wastewater. The exercise proved that measurements of 92 
laboratories were of high quality (> 80% satisfactory results for 6 out of 7 analytes) and that 93 
analytical follow-up is important to assist laboratories in improving robustness of wastewater-based 94 
epidemiology results.  95 
 96 
Keywords 97 
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1. Introduction 99 
The measurement of the human excretion products of illicit drugs in influent wastewater has been 100 
recognized as an alternative and complementary approach for estimating the consumption of illicit 101 
drugs within communities, i.e. the catchment of wastewater treatment plants (WWTPs) [1-3]. The 102 
principle behind wastewater-based epidemiology (WBE) derives from the fact that parent 103 
compounds and/or their human metabolites (i.e., drug residues) are excreted in urine and faeces 104 
following illicit drug use and end up in urban sewer systems [3]. The ability of WBE to provide useful 105 
and timely information on temporal (daily, weekly, monthly, and annually) and spatial (within- and 106 
between-countries) variations in illicit drug consumption has been demonstrated [4-15]. The 107 
European Monitoring Centre for Drug and Drug Addiction (EMCDDA) has recently acknowledged the 108 
added value of WBE to socio-epidemiological methods, such as population surveys, seizure data and 109 
crime statistics, in generating useful and relevant data on population drug use [3]. 110 
 111 
With the aim to improve and optimize WBE, a Europe-wide collaboration was initiated in 2010. Seven 112 
European institutions – University of Antwerp (BE), Eawag (CH), University Jaume I (ES), Mario Negri 113 
Institute (IT), KWR Watercycle Research Institute (NL), Norwegian Institute for Water Research NIVA 114 
(NO), and University of Bath (UK) - established the research group SCORE (Sewage analysis CORe 115 
group Europe) [16]. The ultimate goals of SCORE are (a) to collaborate in the field of WBE to provide 116 
reproducible data; (b) to improve and harmonize the analytical procedures used in different 117 
laboratories to analyze drug residues in wastewater samples; and (c) to perform international studies 118 
comparing illicit drug consumption in communities across the world. To this end, SCORE has 119 
coordinated monitoring studies and exercises to assure the quality of reported data based on agreed 120 
best-practices tackling sampling, storage and analysis. Important results from this collaboration are 121 
multi-city studies demonstrating the usefulness of WBE on an international level to obtain the most 122 
recent data on illicit drug consumption [17-18].  123 
 124 
In order to further optimize and fine-tune WBE, it is imperative to gain knowledge on the sources of 125 
uncertainties that are associated with the approach. In 2013, SCORE performed a thorough 126 
evaluation on the uncertainties of WBE using the best-practice protocols and data that were 127 
available from the comparative Europe-wide WBE research [19]. One of the cornerstones of WBE is 128 
to accurately quantify concentrations of drug residues in wastewater samples by means of reliable 129 
analytical procedures [20]. This requires fully validated analytical procedures before routine analysis 130 
can be initiated and participation in external quality control schemes is, where possible, highly 131 
recommended. External quality control through inter-laboratory exercises are based on the 132 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
31 
 
distribution of the same test samples (in our case prepared by NIVA) to all participants. The latter 133 
analyse all test samples without any knowledge of the concentrations of target analytes and return 134 
their results to the coordinator of the exercise (in our case Eawag, who does not analyse test samples 135 
and does not know the nominal spike value until final compilation of results). The coordinator 136 
converts the submitted results into objective scores that reflect the performance of individual 137 
laboratories and the group. These scores can alert participants of unexpected problems and can 138 
result in actions to be taken [21].  139 
 140 
SCORE initiated inter-laboratory exercises in 2011 in order to develop a quality control scheme for 141 
laboratories that analyze illicit drug residues in wastewater for WBE purposes. Since its debut, the 142 
testing scheme has been carried out annually with increasing participation of different laboratories, 143 
also extending the network outside Europe.  The objectives of the presented interlaboratory exercise 144 
are (a) to illustrate the results of the six-year inter-laboratory testing scheme; (b) to evaluate 145 
advancements achieved over these years and to identify issues still to be resolved; (c) to formulate 146 
recommendations for future inter-laboratory exercises and (d) to propose a robust quality control 147 
system to improve the analytical performance of laboratories analyzing illicit drugs in wastewater.  148 
 149 
2. Setup of the inter-laboratory exercises 150 
2.1. Target analytes 151 
A total of seven illicit drug residues were targeted in the inter-laboratory testing scheme. These 152 
included cocaine (COC), benzoylecgonine (BE, cocaine metabolite), 3,4-methylenedioxy-153 
methamphetamine (MDMA), amphetamine (AMP), methamphetamine (METH), 11-nor-9-carboxy-154 
tetrahydrocannabinol (THC-COOH, THC metabolite), and 6-monoacetylmorphine (6-MAM, heroin 155 
metabolite). These analytes are widely regarded as the main urinary biomarkers of the worldwide 156 
most consumed illicit drugs (COC, MDMA, AMP, METH, cannabis and heroin) and are the focus of 157 
most bioanalytical and WBE initiatives around the world [22]. Certified spiking solutions of each of 158 
the target analytes were supplied by Cerilliant Corporation (Round Rock, Texas, USA). All spiking 159 
solutions were supplied in sealed glass ampoules at 1 mg/mL in methanol. 160 
 161 
2.2. Design of the exercises  162 
The basis of the inter-laboratory testing scheme was to compare the performance of the analytical 163 
procedures employed by participating laboratories. Two separate modules were included to evaluate 164 
in each laboratory (a) the use of correct analytical reference standards and the performance of the 165 
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instrumental analysis (Module 1), and (b) the performance of entire analytical procedures applied to 166 
the analysis of wastewater, including sample preparation (Module 2).  167 
 168 
For Module 1, a methanol solution containing the seven target analytes was used. For Module 2, 169 
samples of tap water and wastewater spiked with the seven analytes were employed. Participants 170 
were asked to use their own in-house developed and validated analytical procedures for the analysis 171 
of the samples. Replicate analysis of each sample was requested (n = 5 for Module 1 and n = 3 for 172 
Module 2). Commonly, sample pre-treatment consisted of filtration followed by solid-phase 173 
extraction for Module 2 samples. All laboratories employed liquid chromatography coupled to mass 174 
spectrometry using mass-labelled internal standards to perform detection and quantification of the 175 
analytes. More information on different techniques, including sample preparation procedures, used 176 
for this type of analyses can be found in Castiglioni et al. (2013) and Hernandez et al. (in press) [19-177 
20]. 178 
Analyte stability in various matrices and conditions is a crucial aspect of any inter-laboratory exercise 179 
as it can substantially affect the outcomes of the analyses, particularly in the absence of certified 180 
reference material in target matrices. Stability of illicit drugs in wastewater has been the subject of 181 
numerous investigations, which were recently reviewed by McCall et al. (2016) [23]. Detailing the 182 
results from all these studies goes beyond the scope of the present paper, however, a brief overview 183 
regarding the analytes targeted in this inter-laboratory exercise is reported here. Both COC and BE 184 
have been shown to be stable in wastewater over multiple weeks when stored refrigerated (4 °C and, 185 
ideally, -20 °C), at low pH and in the dark. Similarly, MDMA, AMP and METH have been shown to be 186 
stable under similar conditions. THC-COOH and 6-MAM, on the other hand, have been shown to be 187 
very sensitive to temperature and, for THC-COOH, low pH.  188 
 189 
2.3. Preparation of test samples 190 
All test samples were prepared by the Norwegian Institute for Water Research (NIVA). Figure 1 and 191 
Table 1 give an overview of the type of test samples included in each year (2011-2016) and the 192 
nominal spiking levels used. The two modules together comprised three matrices (i.e., methanol, tap 193 
water and wastewater) spiked at different concentrations for each of the target analytes. Spiking 194 
concentrations for all matrices changed from year to year to avoid bias and ensure legitimate results. 195 
Certified spiking solutions (1 mg/mL in methanol) were diluted to prepare working solutions at 100 196 
µg/mL or 10 µg/mL in methanol. The working solutions were then used to prepare different test 197 
samples.  198 
The methanol solution (Module 1) containing the analytes was prepared from each of the 100 µg/mL 199 
working solutions. Aliquots (1 mL) of this methanol sample were then transferred to separate glass 200 
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vials and capped. Each vial was accurately weighed and stored at -20 °C ahead of shipment to the 201 
participants. Participants were asked to weigh the samples at arrival and to report deviations from 202 
the weight at preparation. 203 
Spiked wastewater and tap water samples (Module 2) were prepared in a 20 L high-density 204 
polyethylene (HDPE) plastic container pre-washed with tap water and methanol. Twenty litres of cold 205 
tap water or fresh wastewater from VEAS WWTP in Oslo (Norway) were poured into the container, 206 
spiked with different volumes of the 10 µg/mL working standard solutions to obtain relevant 207 
concentrations (at ng/L range) and stirred for 2 h to homogenize the mixture. In 2012, one of the 208 
wastewater samples was used as it is; no spiking with target analytes occurred.  209 
Samples from Module 2 were acidified to adjust the pH to 3.5 in 2012 and 2013. This pH adjustment 210 
was agreed upon by the organizers of the exercise as at that time it was assumed that acidification of 211 
samples was the best way to prevent degradation of the analytes [19]. In 2014-2016, no pH 212 
adjustment of the tap water was performed because of the new insight into the negative effect of 213 
low pH on the stability of THC-COOH in wastewater [23-24]. The changes in used matrices and pH 214 
conditions across the years of the inter-laboratory exercise were the result of experiences of 215 
previous years and of advancements made in the field of WBE.  216 
Aliquots of at least 250 mL were placed in HDPE containers and stored at -20 °C before shipping to 217 
the participants. As real wastewater was used, and which likely contained unknown concentrations 218 
of the target analytes, it was not possible to use a genuine “blank” wastewater sample and nominal 219 
values could thus not be reported. Instead, a total value, comprising background concentrations (x) 220 
and the spiked level, was computed (Table 1).  221 
 222 
2.4. Participants and sample shipping  223 
The inter-laboratory exercises were organized by SCORE and were open to interested participants 224 
from any institution. In order to participate to the exercise, laboratories were required to register 225 
(without any payment) following an invitation sent out by SCORE or through the SCORE website [16]. 226 
Over the period between 2011 and 2016, a total of 37 laboratories from 25 countries participated in 227 
the exercises (for more details on participation in each year, see Table 1). Most of the participating 228 
laboratories (81%) were located in Europe, while the rest (19%) was spread over different continents 229 
(North-America, Asia and Oceania) (Figure 2). The participants located within the European Union 230 
received the test samples, shipped on ice, during the following 24-48 hours while for the remaining 231 
participants from the other continents the average transport time was 2-4 days. Temperature during 232 
shipment was not recorded, but participants were asked to not analyse samples if defrosted upon 233 
reception (responsibility if the participant). 234 
 235 
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2.5. Evaluation of results  236 
Participating laboratories were required to report measured concentrations of the target analytes in 237 
each sample type provided. Results of individual replicates were submitted. Furthermore, 238 
participants had to clearly highlight when concentrations were not quantifiable (i.e., below limits of 239 
quantification) or when the analysis for a certain compound was not performed. Limits of 240 
quantification for each participant were estimated with a fixed protocol and compared to self-241 
assessed limit of quantifications. It was established at a signal-to-noise ratio of 10 using the 242 
quantifier transition from chromatograms of samples spiked at the lowest validation level tested. The 243 
estimated limits of quantification were for all participating laboratories within the same order of 244 
magnitude and comparable to what was reported by each lab based on validation data. Since 2015, 245 
one spiking level was used to evaluate whether the analytical procedures of participants had limit of 246 
quantifications that are relevant in the context of WBE studies. If participants could not report values 247 
for this sample, they were notified that their analytical procedures did not reach relevant sensitivity. 248 
First, the mean concentration (m) of replicates for each participant and for each sample type was 249 
calculated. Secondly, after testing for normality, a Grubbs’ test was performed to identify outliers 250 
which were excluded from further analysis. From the remaining means, the group’s mean [i.e., mean 251 
of means (M)] and the group’s standard deviation (SD) were computed. To evaluate the performance 252 
of each participant (), z-scores () for every analyte and sample type were calculated as follows: 253 
 =
 −
	
 
Following the ISO standard, a laboratory passed the inter-laboratory exercise when its |z| ≤ 2 [21, 254 
25]. Participants with results that were identified as outliers (Grubb’s test) or had |z|-values > 2 were 255 
individually notified about the deviation and were allowed to recheck their submitted values for 256 
inconsistencies or errors. Note that no detail (, M) was supplied with the notification of the 257 
deviation in order to maintain impartiality. If these laboratories were able to supply a viable 258 
explanation (such as transcription errors), they were allowed to resubmit corrected results. If 259 
accepted, newly submitted values were used to compute updated values for , M, SD and . 260 
The purpose of this iterative process lies in the goal of SCORE to advance and improve WBE. The 261 
inter-laboratory exercise was therefore used to assist laboratories in optimizing their analytical 262 
procedures and improve the overall performance. 263 
 264 
3. Results and Discussion 265 
3.1. Assigned value: group’s mean vs. nominal concentration  266 
 267 
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The z-score was calculated relative to the group’s mean (M). The main reasons for using M instead of 268 
the nominal concentration (i.e. spiking levels) as reference in the context of this inter-laboratory 269 
exercise are [21, 25]: 270 
(vii) Multiple scientific evaluations repeatedly revealed that spiking concentration levels did 271 
not necessarily display sufficient reliability to be used as an assigned value to calculate z-272 
scores; 273 
(viii) For wastewater samples, the use of spiking levels as assigned value is out of the question 274 
because of the presence of unknown concentrations of the analytes (no nominal values 275 
exist);  276 
(ix) There is a sufficient number of laboratories that participated in the exercises along the 277 
years (Table 1); 278 
(x) Certified reference materials (CRMs) for analyzing illicit drugs in water samples are not 279 
available;  280 
(xi) No recognised reference laboratories for this type of analysis exist; 281 
(xii) The chosen approach was agreed by the participants as they were all informed on the 282 
calculation and evaluation procedures applied.  283 
 284 
Figure 3 shows the deviation of the group’s mean (M) from the nominal concentration (spiking level) 285 
for the methanol and tap water test samples. For the wastewater samples included in the exercises 286 
from 2012-2014, it is impossible to generate any meaningful plot because of the unknown 287 
background concentrations of the analytes present in this matrix.  288 
The results showed that the deviation of the group’s mean (M) from the nominal concentration was 289 
mostly < 25%, which was regarded by SCORE as an acceptable variability. The deviation for the 290 
matrix-free samples (i.e., methanol solvent) was mostly well below this 25% limit and suggested that 291 
in all laboratories, the reference standards (both native and isotope-labelled) used and the 292 
instrumental analysis (e.g. calibration and instrumental parameters) did not lead to substantial bias 293 
in the analysis of the target analytes, except for 6-MAM. However, in the presence of matrix, 294 
deviations of more than 25% occurred more often, in particular for 6-MAM and THC-COOH. 295 
Concentrations of 6-MAM were systematically underreported, for both the standard solution and tap 296 
water samples. In some occasions, the deviation amounted up to 60%. This systematic 297 
underestimation of 6-MAM could be due to: (i) inaccuracies during the preparation and spiking of the 298 
test samples (e.g. preparation and dilution of stock solution); (ii) stability issues of this analyte during 299 
preparation of the test samples and during storage and sample handling; (iii) issues with the 300 
analytical procedures applied by the laboratories.  301 
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The analysis of THC-COOH in the methanol samples gave acceptable results (deviation <25% and no 302 
systematic error), while deviations of up to 90% were observed in tap water samples in 2013 and 303 
2014. It is important to highlight that tap water samples were acidified in 2013 and, in the following 304 
year, sample acidification before filtration was still performed by multiple participants. These were 305 
later shown to have a negative impact on the measured concentrations of THC-COOH because of 306 
adsorption issues [23-24, 26]. Acidification may be the cause of the high variability observed for this 307 
analyte, but this is clearly not the whole picture. In fact, Causanilles et al. (2017) demonstrated that 308 
different (combinations of) parameters (pH, filtration, sorption) can have an influence on the analysis 309 
of THC-COOH in wastewater [26].  310 
For COC, all samples across the different years showed deviations <25%, except for the three tap 311 
water samples in 2015. The nature of this systematic deviation (only one year) indicates the error 312 
likely occurred in the preparation of these test samples.  313 
 314 
3.2. Influence of different matrices and concentration levels on the group’s variability 315 
The influence of the different matrix types on the performance of participating laboratories was 316 
assessed through analysis of the datasets from all years. Figures 4 and 5 illustrate the influence of the 317 
three matrices on the relative standard deviation (RSD) of the group. Overall, a lower RSD for the 318 
methanol samples compared to the waste- and tap water samples was observed (Wilcoxon rank sum 319 
test p-value < α = 0.05). This observation was not surprising considering that concentrations of the 320 
standard solution samples were in the µg/L range while in tap water and wastewater, samples 321 
concentrations were in the ng/L range. Furthermore, analysis of the methanol solution samples did 322 
not require any substantial sample preparation (i.e., direct injection with/without further dilution) 323 
compared to waste- and tap water samples, which required pre-concentration. A significant 324 
difference between the RSDs for tap water and wastewater samples was observed (Wilcox rank sum 325 
test p-value = 0.01, α = 0.05). For THC-COOH, high RSDs were observed for tap water and wastewater 326 
samples compared to the other analytes. Likewise, in the methanol solution, high RSDs were 327 
observed on several occasions (Figure 4). These findings further suggest that there are some issues 328 
with the analysis of this particular compound in water samples, as discussed earlier (Figure 3). 329 
The difference in RSDs between tap and wastewater samples was further investigated using ANOVA 330 
(after log transforming the data to correct for deviation from normality and heteroscedasticity). 331 
Statistical analysis revealed that the spiking level showed the most significant influence on the 332 
group’s RSD (F(1,98) = 121.5, p < 0.0001), followed by the matrix type (F(1,98) = 10.9, p < 0.001) and 333 
the compound under analysis (F(6,98) = 3.0, p < 0.01). Because the matrix type was not the most 334 
influential parameter, the use of spiked tap water samples was deemed adequate for the purposes of 335 
the present inter-laboratory exercise. In fact, when using wastewater samples, (a) differences in 336 
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matrix effects occur between locations and (b) background concentrations of the analytes in 337 
wastewater are unknown and uncontrollable. As a result, it was not considered possible to use 338 
‘representative’ wastewater for the purpose of this inter-laboratory exercise. Furthermore, by using 339 
tap water, labour and logistic costs linked to the preparation and distribution of additional samples 340 
to the participants could be reduced significantly. Issues related to the biodegradation and sorption 341 
of target analytes in wastewater during shipment could also be reduced. Furthermore, our study, 342 
including data over a six-year period, provides unique insights into how the molecular properties of 343 
the analytes, concentration levels and matrix type affect laboratory performance in the context of 344 
(waste)water analysis. The information and experience gained could hence be useful for other inter-345 
laboratory exercises confronted with similar matrices.  346 
 347 
3.3. Performance of laboratories 348 
The evaluation of the results obtained by all laboratories discussed hereafter is based on the 349 
performances with the spiked tap water samples, as this matrix was shown to be appropriate (see 350 
section 3.2) and because of the issues with wastewater samples mentioned earlier (i.e., unknown 351 
background concentrations and potential stability issues). Figure 6 provides an overview of the 352 
proportion of satisfactory results per analyte type in the period of 2013-2016. A satisfactory result is 353 
regarded as a |z|-value ≤ 2 [21, 25]. Grubb’s outliers, non-detects (reported as below limit of 354 
quantification) and |z|-values > 2 are regarded as unsatisfactory. In the supporting information, 355 
detailed results for each laboratory over the different years are shown. The plots give an overview of 356 
the distribution of the z-scores of the group for the different years, matrices and spiking levels and 357 
detailed plots for results of the individual laboratories (including intra-laboratory variation). 358 
In general, for BE, COC, MDMA, and AMP, the group’s performances were acceptable, with > 90% of 359 
satisfactory results. For METH and 6-MAM, the satisfactory result were around 80% in 2013. This can 360 
be linked to the fact that 3 out of 15 (METH) and 3 out of 10 (6-MAM) participants did not detect the 361 
analytes in the test samples. In 2014-2016, acceptable results for these two analytes were obtained, 362 
probably due to the higher concentration levels and improved performance of the analytical 363 
procedures of the participants. The unsatisfactory results obtained for THC-COOH analysis over years 364 
have drawn the attention of SCORE and triggered a further investigation of the effect that different 365 
pre-analytical steps (filtration and pH adjustment) have on the accuracy the analysis of this 366 
compound in wastewater [26].  367 
It is important to mention that the aim of SCORE is to improve the reliability of WBE studies. 368 
Therefore, support was provided to laboratories that showed unsatisfactory results by means of 369 
short-term visits of a SCORE member and/or optimization of the analytical procedures (assistance 370 
with sample preparation and method validation). In most cases, this resulted in positive outcomes 371 
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for these laboratories in following exercises. This highlighted the need for follow-up of inter-372 
laboratory exercises combined with a continuous support to all participants.  373 
 374 
The z-scores regarding different concentrations of each analyte were visualised in scatter biplots (i.e., 375 
Youden plots, Figure 7) to assess the sources of variability among the participating laboratories. 376 
Inter-laboratory variation predominates if results were clustered in the upper right and lower left (= 377 
white) quadrants, while intra-laboratory variation predominates if results are clustered in the upper 378 
left and lower right (= grey) quadrants [25]. Furthermore, the distances of the plotted point relative 379 
to the 45-degree reference line and to the (0, 0) point (i.e. the Manhattan median) are both useful 380 
for the interpretation of inter-laboratory data. Points that lie close to the 45-degree reference line 381 
but far from the Manhattan median indicate a systematic error. Points that lie far from the reference 382 
line suggest large random errors. The majority of the participating laboratories was found within the 383 
white quadrants (Figure 7), meaning that inter-laboratory variability was predominant over the intra-384 
laboratory variability for all seven analytes. Only a few laboratories were occasionally outside of the 385 
|z|-values > 2 boundaries. For the latter, this implies large total errors, which were mainly 386 
systematic, as results were close to the 45-degree reference line but distant from the origin. 387 
Moreover, it should be noted that no recurrent erroneous results were observed, i.e., there were no 388 
laboratories with anomalous results for a certain analyte reported across different years. This 389 
supports the hypothesis that the observed errors were rather incidental and/or that these 390 
laboratories had improved their analytical procedures.   391 
 392 
3.4. Sources of variations and recommendations 393 
The six-year data from inter-laboratory exercises for the analysis of illicit drug residues in water 394 
samples revealed variations linked to its setup and allowed to provide recommendations to improve 395 
future exercises. First, this study shows that the group’s mean should be used to evaluate 396 
performance of laboratories rather than the nominal (spiked) value. However, it is important that 397 
nominal values should always be considered to exclude pre-analytical issues, as demonstrated for 398 
THC-COOH. This observation triggered further investigations and recommendations to improve the 399 
WBE approach to estimate cannabis use [26]. Second, since concentration levels were found to be 400 
the main factor influencing performances (Figure 4, see section 3.2), spiking levels should be chosen 401 
carefully, and reflecting concentrations expected in real samples. Particularly, for the methanol 402 
standard samples, the use of different concentrations (e.g. Youden couple) instead of a single (high) 403 
level, as we did, will be useful to improve the assessment of laboratory performances. Third, it is 404 
important to prepare and transport test samples in the most optimal way in order to avoid stability 405 
and adsorption problems. The issues observed with 6-MAM and THC-COOH when samples were 406 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
39 
 
acidified (see section 3.1) are a good example and highlight the need to consider other preservatives 407 
(e.g., sodium metabisulphite (Na₂S₂O₅) or sodium azide (NaN3)) to ensure analyte stability during 408 
transport and storage [27-28]. Furthermore, future inter-laboratory exercises should include an extra 409 
analysis of the test samples by the preparing laboratory directly after preparation of the test samples 410 
before freezing and shipment. This will improve understanding of the differences between the 411 
nominal spike and the assigned value. 412 
Based on the experiences acquired from these six rounds of inter-laboratory exercises, 413 
recommendations related to analytical procedures used by individual laboratories for measuring 414 
illicit drugs and metabolites in wastewater can be formulated. Laboratories can freely choose their 415 
preferred sample preparation procedure and detection/quantification technique, but we strongly 416 
suggest that the methods comply with the following features. First, mass-labeled internal standards 417 
should be used for each analyte and spiked in samples before any filtration step. Second, pH 418 
adjustment - when needed - has to be conducted after internal standard spiking and/or filtration. 419 
This is particularly relevant for the analysis of THC-COOH in wastewater [26]. Third, freeze-thaw 420 
cycles of the samples should be minimized. Fourth, in-house quality control samples (e.g. spiked tap 421 
water or wastewater) should be prepared and analysed with each sample batch. Furthermore, 422 
centrifugation instead of filtration can be an alternative way to avoid the blockage and clogging of 423 
solid-phase extraction cartridges with particulates present in the wastewater.  424 
 425 
4. Conclusions 426 
This study presents, for the first time, the results of an inter-laboratory testing scheme for the 427 
analysis of illicit drugs and metabolites in wastewater. By repeating this exercise for six years, we 428 
were able to improve the set-up of the testing scheme substantially, based on experiences gained 429 
over the years (e.g. matrix to be used, sample parameters, spiking levels) and to establish a reliable 430 
quality control system. The existence of such system is important to ensure high-quality data of WBE 431 
monitoring studies that can be used by stakeholders to obtain the most recent data on spatial and 432 
geographical trends in illicit drug use on a national and international scale. 433 
The results of the exercise highlighted the importance of using the group’s mean rather than the 434 
nominal value as the assigned value, in particular due to the lack of certified reference materials for 435 
testing illicit drugs in wastewater. An investigation of the RSD associated with reported results 436 
showed that the most influential parameter was the spiking level, not the instrument (method) used 437 
or the type of matrix (i.e., tap or wastewater). Consequently, tap water was chosen for future 438 
exercises as it presents various advantages. Specifically, it allows to control spiking levels more easily, 439 
which is not possible with wastewater as unknown background concentrations exist. In fact, 440 
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substantial variations in composition and analyte concentrations occur, even within wastewater 441 
collected from a unique location.  442 
Regarding laboratories performances, the results from the inter-laboratory exercise show that these 443 
were generally satisfactory for COC, BE, MDMA, AMP and METH. An improvement was observed 444 
over the years and, in its latest round in 2016, more than 90% of the participating laboratories 445 
reported results |z|-value ≤ 2. In the case of 6-MAM and THC-COOH, results from the exercise 446 
showed that important pre-analytical issues still exist, and that sample pH has an important influence 447 
on the stability of the latter analytes. Whilst these issues still need to be solved, it is important to 448 
notice that none of the participating laboratories repeatedly (i.e., systematically) reported erroneous 449 
results for the same analyte across multiple years, emphasising the improvements in analytical 450 
performances which took place over the years.  451 
The results illustrate the effectiveness of the inter-laboratory testing scheme in assessing and 452 
improving laboratory performance in the framework of illicit drug analysis in wastewater. The 453 
exercise proved that measurements of individual laboratories were of high quality and that analytical 454 
follow-up is important in order to assist laboratories in improving the robustness and accuracy of 455 
WBE results. The set-up and procedures used in this exercise for the measurement of illicit drugs in 456 
wastewater and experiences gained during the six-year period are of importance for the 457 
development of other quality control systems dealing with the measurement of pharmaceuticals, 458 
personal care products and other contaminants in aqueous matrices.  459 
Wastewater-based epidemiology has gained importance, as numerous national and international 460 
organisations rely on its measurements to improve quantification of illicit drug use. Consequently, 461 
additional efforts will be needed in future to ensure the impeccable quality of reported results and 462 
tackle the existing and upcoming challenges. In particular, improving analytical performances for 463 
important compounds such as 6-MAM and THC-COOH and, at the same time, adapting protocols to 464 
integrate an ever growing number of relevant substances (e.g., new psychoactive substances) are 465 
among the main challenges that laboratories will face in future.   466 
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Figure 1. Inter-laboratory overview and scheme of the sample preparation and shipment for Module 
2. 
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Figure 2. Map with location of the participants of the inter-laboratory exercises 
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Figure 3. Deviation of the assigned value (= group’s mean) from the nominal value (= spiking level)  
for the standard solution (top) and the tap water samples (bottom) in relation to the assigned value 
for the seven analytes. The dotted line represents 25% deviation. Entries with deviations > 25% are 
marked with the year of the inter-laboratory exercise. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
49 
 
 
Figure 4. Relative standard deviation of the group in relation to the assigned value M (logarithmic 
scale) for the three matrices [standard solution (blue), tap water (green) and wastewater (red)] and 
seven analytes. All years (2011-2016) included. 
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Figure 5. Boxplot showing the difference in the group’s RSD for the three different matrices (MEOH = 
standard solution; TW = tap water; WW = wastewater) in 2013 and 2014 for all analytes. 
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Figure 6. Percentage of participants with satisfactory results (|z| ≤ 2) for tap water samples spiked 
with seven analytes. The dotted line represents 90% satisfactory level. 
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Figure 7. Youden plots with z-scores of the low concentration value (x-axis) and the z-scores of the 
high concentration value (y-axis) for the seven analytes in tap water across the years. Each 
participant is presented by a unique number. The inner rectangle captures satisfactory z-scores. 
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Table 1. Overview of inter-laboratory exercises and the number of participants from 2011-2016. For 
the wastewater samples, the ‘x’ represents unknown background concentrations. L = concentration 
level; P = amount of participants. 
 2011 2012 2013 2014 2015 2016 
L P L P L P L P L P L P 
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12 
120; 
147 
12 800 15 900 21 60 26 20 26 
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50; 
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12 56; 132 13 700 15 750 21 120 26 40 26 
METH 
50; 
500 
12 
128; 
134 
13 200 15 150 21 80 26 50 26 
THC-
COOH 
50; 
500 
10 
226; 
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Highlights 
 
First worldwide inter-laboratory exercise for analysis of illicit drugs in wastewater 
Results revealed (pre-)analytical issues for certain analytes 
Six years of exercises have resulted in optimized procedures and protocols 
Quality control system will make wastewater-based epidemiology results more reliable 
